412402004: Hepatitis B virus recombinant vaccine (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2467854015 Hepatitis B virus recombinant vaccine (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

2473980018 Hepatitis B virus recombinant vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

854191000241110 vaccin recombinant contre le virus de l'hépatite B fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

854251000241113 vaccin recombinant contre l'hépatite B fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

854261000241111 vaccin recombinant hépatite B fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
vaccin recombinant contre le virus de l'hépatite B	Is a	vaccin contre l'hépatite B	false	Inferred relationship	Some
vaccin recombinant contre le virus de l'hépatite B	Is a	allergène médicamenteux	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
vaccin recombinant contre le virus de l'hépatite B	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some	1
10 µg/0,5 ml du vaccin contre l'hépatite B recombinant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some
Hepatitis b virus vaccine re 10mcg/0.5 mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some
Hepatitis b virus vaccine re 10mcg/.5mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some
seringue préremplie de 0,5 mL avec 20 microgrammes/mL du vaccin injectable contre l'hépatite B (ADNr)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some
Hib-HB Haemophilus influenzae de type B + hépatite B pédiatrique non spécifié	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some	2
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some
seringue préremplie de 0,5 mL avec une suspension injectable d'antigène de surface du virus de l'hépatite B recombinant 10 microgrammes, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, vaccin acellulaire contre la coqueluche 25 microgrames	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some
Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some
vaccin contre la diphtérie, le tétanos, la coqueluche et l'hépatite B recombinant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some	3
vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite et de l'hépatite B recombinant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some	4
vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite, l'hépatite B (recombinant) et Haemophilus influenzae de type B (recombinant)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some	5
flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some	1
Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some	6
seringue préremplie de 0,5 mL avec une suspension injectable d'antigène de surface du virus de l'hépatite B recombinant 10 microgrammes, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, vaccin acellulaire contre la coqueluche 25 microgrames	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccin recombinant contre le virus de l'hépatite B	Inferred relationship	Some	1

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)